An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory response
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In schistosomiasis, chronic parasite egg-induced granuloma formation can lead to tissue destruction and fibrosis, which causes much of the morbidity and mortality associated with this disease. Here we show the importance of IL-13 in the pathogenesis of schistosomiasis, and demonstrate, perhaps for the first time, the therapeutic efficacy of an IL-13 inhibitor, sIL-13Ralpha2-Fc, in the control of hepatic fibrosis. T-helper type 2 (Th2) cytokines dominate the immune response in mice infected with Schistosoma mansoni, yet the specific contributions of IL-13 and IL-4 to the development of fibrosis were not previously investigated. Our studies demonstrate that both cytokines play redundant roles in granuloma formation, which explains the ability of IL-4-deficient mice to form granulomas around eggs. More importantly, however, these studies demonstrate that IL-13 is the dominant Th2-type cytokine regulating fibrosis. IL-13 stimulated collagen production in fibroblasts, and procollagen I and procollagen III mRNA expression was decreased in sIL-13Ralpha2-Fc-treated mice. Moreover, the reduction in fibrosis observed in IL-4-deficient mice was much less pronounced than that in sIL-13Ralpha2-Fc-treated animals. Fibrosis is a major pathological manifestation of a number of allergic, autoimmune, and infectious diseases. Thus, our findings provide evidence that IL-13 inhibitors may be of general therapeutic benefit in preventing damaging tissue fibrosis resulting from Th2-dominated inflammatory responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-11, a member of the IL-6/gp130 cytokine family, may be one such target as it was recently shown to integrate pro-fibrotic signals emanating from both pathways146–149”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617 · cited 2×
“IL-13 was also recently shown to play a central role in murine asthma (30, 31).”
BackgroundSelf-citationRequirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Self-citationZhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719 · cited 1×
“Indeed, the targeted pulmonary expression of IL-13 was shown to cause mucus cell metaplasia, airway fibrosis, and nonspecific airway hyperreactivity (43).”
BackgroundStat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628 · cited 1×
“In contrast to these observations, granuloma formation and the development of hepatic fibrosis was severely impaired in Stat6-deficient mice (10), which display a major defect in the production of several Th2-associated cytokines (39).”
ResultTwo Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline.
Bergman, I., & Loxley, R. (1963) · Analytical Chemistry · doi:10.1021/ac60205a053 · Cited by 1,525 · cited 1×
“Specifically, hepatic collagen was measured as hydroxyproline by the technique of Bergman and Loxley after hydrolysis of a 200-mg portion of liver in 5 mL of 6 N HCl at 110°C for 18 hours (35).”
MethodDisruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundLe Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D., & Paul, W. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.921 · Cited by 954 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundPearce, E. J., Caspar, P., Grzych, J. M., Lewis, F. A., & Sher, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.159 · Cited by 765
Urban, J. F., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., & Finkelman, F. D. (1998) · Immunity · doi:10.1016/s1074-7613(00)80477-x · Cited by 580
Self-citationGrzych, J. M., Pearce, E., Cheever, A., Caulada, Z. A., Caspar, P., Heiny, S., Lewis, F., & Sher, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1322 · Cited by 542
Self-citation
Cited by
Items 301–400 of 608
Myocardial fibrosis seen through the lenses of T-cell biology
Ramos, G. C., Hofmann, U., & Frantz, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.018 · Cited by 49
Ahadome, S. D., Mathew, R., Reyes, N. S., Mettu, P. S., Cousins, S. W., Calder, V. L., & Saban, D. R. (2016) · JCI Insight · doi:10.1172/jci.insight.87012 · Cited by 44
Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies
Abdul-Ghani, R. A., & Hassan, A. A. (2010) · Parasitology Research · doi:10.1007/s00436-010-1855-5 · Cited by 41
“Chiaramonte et al. (1999) showed that recombinant IL-13 stimulated collagen synthesis in fibroblasts, and its harmful effects may be mediated directly through its profibrogenic activity.”
BackgroundT cell substance P receptor governs antigen-elicited IFN-γ production
Blum, A. M., Metwali, A., Elliott, D. E., & Weinstock, J. V. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00271.2002 · Cited by 41
“IL-4 is important for the phenotypic expression of the Th2 response in murine schistosomiasis (12, 28, 31), whereas IL-5 influences granuloma eosinophil development (18).”
BackgroundCurrent status and future prospects for a vaccine against schistosomiasis
Lebens, M., Sun, J., Czerkinsky, C. C., & Holmgren, J. R. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.3.315 · Cited by 41
M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection
Zhang, H., Li, Z., & Li, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.648539 · Cited by 45
“On the contrary, T helper type 2 cells (Th2 cells) is likely to promote the TGF-βmediated fibrosis via the production of IL-4 and IL-13 (54).”
BackgroundO’Toole, M., Legault, H. M., Ramsey, R., Wynn, T. A., & Kasaian, M. T. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02921.x · Cited by 41
Self-citationTumor cells secreting IL-13 but not IL-13R 2 fusion protein have reduced tumorigenicity in vivo
Ma, H.-L. (2004) · International Immunology · doi:10.1093/intimm/dxh105 · Cited by 39
“In addition, IL-13Ra2 has been engineered as a soluble IL-13Ra2Fc fusion protein that has successfully blocked several functions attributed to IL-13 including fibrogenesis ( 20 ), airway hyperactivity (21) and gastrointestinal parasite expulsion (22).”
BackgroundAntifibrosis: To Reverse the Irreversible
Paz, Z., & Shoenfeld, Y. (2009) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8157-7 · Cited by 43
David, M. D., Bertoglio, J. H., & Pierre, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206352 · Cited by 40
“…a soluble recombinant IL-13Ra2 protein has been constructed, which efficiently inhibits IL-13 activity in mouse models of Th2 cell-mediated reactions induced by Schistosoma mansoni eggs and of allergic lung diseases (Grunig et al., 1998; Wills-Karp et al., 1998; Chiaramonte et al., 1999).”
BackgroundT helper type-2 cytokine responses: potential therapeutic targets
Jarnicki, A., & Fallon, P. G. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00077-8 · Cited by 42
“Data showing that IL-13Ra2 regulates IL-13-induced fibrosis [35] extended findings from earlier studies [37,38], and raises the possibility of using IL-13Ra2 therapeutically as a decoy receptor to treat fibrotic diseases.”
BackgroundExosomes: Carriers of Pro-Fibrotic Signals and Therapeutic Targets in Fibrosis
Li, M., Jiang, M., Meng, J., & Tao, L. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191209161443 · Cited by 38
Chu, D., Du, M., Hu, X., Wu, Q., & Shen, J. (2011) · Parasitology · doi:10.1017/s0031182011001065 · Cited by 40
“Each bar represents the mean and standard deviation. schistosomiasis (Chiaramonte et al. 1999, 2001).”
BackgroundCytokine profile associated with chronic and acute human schistosomiasis mansoni
de Morais, C. N. L., de Souza, J. R., Melo, W. G., Aroucha, M. L., Miranda, P. J., Domingues, A. L. C., Abath, F. G. C., & Montenegro, S. M. L. (2008) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762008000600009 · Cited by 38
“IFN-γ was the major downregulator of fibrosis, whereas IL-4 was shown to play the role of pro-inflammatory cytokine (Chensue et al. 1997), and IL-13 was implicated in fibrogenesis (Chiaramonte et al. 1999a, b, Finkelman et al. 1999).”
BackgroundFormentini, A., Prokopchuk, O., Sträter, J., Kleeff, J. H., Grochola, L. F., Leder, G. H., Henne‐Bruns, D., Korc, M., & Kornmann, M. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0550-9 · Cited by 42
“IL-13 also acts on fibroblasts and has been shown to mediate fibrosis in allergic asthma and Schistosoma mansoni-induced hepatic fibrosis [37, 38].”
BackgroundUrokinase Plasminogen Activator Induces Pro-Fibrotic/M2 Phenotype in Murine Cardiac Macrophages
Meznarich, J., Malchodi, L., Helterline, D., Ramsey, S. A., Bertko, K., Plummer, T., Plawman, A., Gold, E., & Stempien-Otero, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057837 · Cited by 36
RGS16 Attenuates Pulmonary Th2/Th17 Inflammatory Responses
Shankar, S. P., Wilson, M. S., DiVietro, J. A., Mentink‐Kane, M. M., Xie, Z., Wynn, T. A., & Druey, K. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103781 · Cited by 39
Self-citationWynn, T. A., Hesse, M., Utay, N. S., Kaviratne, M., Hoffmann, K. F., Chiaramonte, M. G., Reiman, R. M., Cheever, A. W., Sypek, J. P., & Mentink‐Kane, M. M. (2004) · Hepatology · doi:10.1002/hep.20102 · Cited by 38
“09 (N) (7) (7) (7) (4) (4) (4) B PsKO 4.”
Self-citationAbonyo, B. O., Alexander, M. S., & Heiman, A. S. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00032.2005 · Cited by 42
“(11) and increased numbers of epithelial cells in bronchoal-”
BackgroundMitochondrial Dysfunction in Advanced Liver Disease: Emerging Concepts
Zhang, I. W., López‐Vicario, C., Duran‐Güell, M., & Clària, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.772174 · Cited by 40
“, TGFβ and IL-13), signaling through the succinate-GPR91TGFβ pathway, mitochondrial ROS and apoptotic bodies arising from dying hepatocytes (Chiaramonte et al., 1999; Jiang et al., 2009; Pellicoro et al., 2014; Li et al., 2015a).”
BackgroundType 2 immunity: a two-edged sword in schistosomiasis immunopathology
Aziz, N. A., Musaigwa, F., Mosala, P., Berkiks, I., & Brombacher, F. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.06.005 · Cited by 43
Herbert, D. R., Orekov, T., Perkins, C. L., Rothenberg, M. E., & Finkelman, F. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4948 · Cited by 37
“Instead, our studies are consistent with a hypothesis that IL-4/IL-13 act directly upon liver fibroblasts (hepatic stellate cells) to drive collagen synthesis (19, 38).”
MethodResultMorimoto, M., Zhao, A., Sun, R., Stiltz, J. A., Madden, K. B., Mentink‐Kane, M. M., Ramalingam, T. R., Wynn, T. A., Urban, J. F., & Shea‐Donohue, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804299 · Cited by 36
“In the present study, IL-13 gene expression was highly up-regulated compared with IL-4, consistent with the higher IL-13 production reported in other infections (24).”
ResultSelf-citationLiver Regeneration and Immunity: A Tale to Tell
Di-Iacovo, N., Pieroni, S., Piobbico, D., Castelli, M., Scopetti, D., Ferracchiato, S., Fazia, M. A. D., & Servillo, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021176 · Cited by 46
“In the context of fibrosis an immune response of type Th2 is involved, where inflammatory environment is enhanced by an increase of IL-4 and IL-13 and myofibroblasts deposit an excessive extracellular matrix [164,165].”
BackgroundExploiting worm and allergy models to understand Th2 cytokine biology
Ramalingam, T. R., Reiman, R. M., & Wynn, T. A. (2005) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000182542.30100.6f · Cited by 37
Self-citationLee, Y., & Friedman, S. L. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385233-5.00006-4 · Cited by 41
Immune response and pathogenesis of neuroschistosomiasis mansoni
Ferrari, T. C. A., Gazzinelli, G., & Corrêa‐Oliveira, R. (2008) · Acta Tropica · doi:10.1016/j.actatropica.2008.02.010 · Cited by 35
El-Kady, I. M., Lotfy, M., Badra, G., El-Masry, S. A., & Waked, I. A. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2005.01529.x · Cited by 35
Altered innate immune response in farmers and smokers
Sahlander, K., Larsson, K., & Palmberg, L. (2009) · Innate Immunity · doi:10.1177/1753425909106317 · Cited by 35
“The perpetual increase of IL-13 producing Th2 cells may induce negative tissue effects as IL-13 and IL-4 are involved in the pathogenesis of a number of inflammatory disorders characterised by tissue remodelling.(19,38,39) Recently, it was shown that IL-13 signalling trough the IL-13 2 receptor induces production of t…”
BackgroundFleury, M., Belkina, A. C., Proctor, E. A., Zammitti, C. A., Simms, R. W., Lauffenburger, D. A., Snyder-Cappione, J. E., Lafyatis, R., & Dooms, H. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40399 · Cited by 37
“IL-13, for example, is a potent inducer of collagen production (44).”
BackgroundRole of 5-Lipoxygenase in IL-13-Induced Pulmonary Inflammation and Remodeling
Shim, Y. M., Zhu, Z., Zheng, T., Lee, C. G., Homer, R., Ma, B., & Elias, J. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1918 · Cited by 34
Attenuated liver fibrosis in the absence of B cells†
Holt, A. P., Stamataki, Z., Adams, D., Jaeschke, H., Mullen, K. D., & Moradpour, D. (2006) · Hepatology · doi:10.1002/hep.21155 · Cited by 34
Abouel-Nour, M. F., Lotfy, M., Attallah, A. M., & Doughty, B. L. (2006) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762006000400004 · Cited by 34
“Blocking of IL-13 in experimental animals almost completely abrogated granuloma development and pulmonary eosinophilia ( Chiaramonte et al. 1999 ).”
BackgroundRole of CCR5 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling
Ma, B., Liu, W., Homer, R., Lee, P. J., Coyle, A. J., Lora, J. M., Lee, C. G., & Elias, J. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4968 · Cited by 34
Jinnin, M., Ihn, H., Asano, Y., Yamane, K., Trojanowska, M., & Tamaki, K. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700090 · Cited by 34
Interleukin-13 and Leukotrienes
Elias, J. A., Lee, C. G., Zheng, T., Shim, Y. M., & Zhu, Z. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.f264 · Cited by 36
An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicum
Long, X., Chen, Q., Zhao, J., Rafaels, N., Mathias, P., Liang, H., Potee, J., Campbell, M., Zhang, B., Gao, L., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135360 · Cited by 28
“IL-13 mediates hepatic stellate cell activation and the subsequent secretion of collagen contributes to the development of liver fibrosis [23 – 25].”
Negative Regulation of Schistosoma japonicum Egg-Induced Liver Fibrosis by Natural Killer Cells
Hou, X., Yu, F., Man, S., Huang, D., Zhang, Y., Liu, M., Ren, C., & Shen, J. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001456 · Cited by 33
“mansoni egg deposition leads to the development of Th2 response, which promotes the development of liver fibrosis [4,23,24].”
BackgroundHow Does High-Fat Diet Induce Adipose Tissue Fibrosis?
Pessin, J. E., & Kwon, H. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318271fdb9 · Cited by 36
“Fibrosis is closely linked with TH2 immune responses, and especially IL-13, produced by TH2 CD4 + T cells, is the major cytokine to mediate tissue fibrosis.(31,36,37) The expression of IL-13 is increased in tissues and bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis, sarcoidosis, and liver fibrosis.”
BackgroundHTLV-1 modifies the clinical and immunological response to schistosomiasis
Porto, A. F., Santos, S., ALCÂNTARA, L., Guerreiro, J. B., PASSOS, J., González, T., Neva, F. A., GONZALEZ, D., Ho, J. L., & Carvalho, E. M. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02508.x · Cited by 33
Park, J., Taube, C., Yang, E. S., Joetham, A., Balhorn, A., Takeda, K., Miyahara, N., Dakhama, A., Donaldson, D. D., & Gelfand, E. W. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.046 · Cited by 33
Self-citationEosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients
Silveira-Lemos, D., Teixeira‐Carvalho, A., Martins‐Filho, O. A., Oliveira, L. F. A., Costa-Silva, M. F., Matoso, L. F., de Souza, L. J., Gazzinelli, A., & Corrêa‐Oliveira, R. (2008) · Acta Tropica · doi:10.1016/j.actatropica.2008.04.006 · Cited by 33
Fabre, V., Wu, H.-W., Pond‐Tor, S., Coutinho, H. M., Acosta, L. P., Jiz, M., Olveda, R. M., Cheng, L., White, E. S., Jarilla, B. R., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq099 · Cited by 32
Host-Directed Therapies for Parasitic Diseases
Singh, B., Varikuti, S., Halsey, G., Volpedo, G., Hamza, O., & Satoskar, A. R. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0439 · Cited by 33
Wang, Y., Fan, X., Lei, N., He, X., Wang, X., Luo, X., Zhang, D., & Pan, W. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00101 · Cited by 34
“The processed liver sections were then subjected to hematoxylin-eosin (HE) and Masson’s trichrome staining to evaluate the granuloma size and hepatic fibrosis severity, which can be quantified by measuring the fibrosis grade of liver tissue as previously reported (Chiaramonte et al., 1999).”
MethodNegrão‐Corrêa, D. A., Fittipaldi, J., Lambertucci, J. R., Teixeira, M. M., Antunes, C. M. D. F., & Carneiro, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088042 · Cited by 32
Schistosoma japonicum egg granuloma formation in the interleukin‐4 or interferon‐γ deficient host
Hirata, M., Kage, M., Hara, T., Yoneda, Y., Zhang, M., & Fukuma, T. (2001) · Parasite Immunology · doi:10.1046/j.1365-3024.2001.00382.x · Cited by 32
Li, X., Shen, J., Zhong, Z., Peng, J., Wen, H., Li, J., Luo, Q., & Wei, W. (2010) · Parasitology · doi:10.1017/s003118201000003x · Cited by 32
“…mice as well as IL-13 antagonist in wild mice demonstrated that IL-13 and IL-13-/IL-4Ra, and the Stat6-dependent pathway represented a central mechanism regulating fibrosis in murine schistosomiasis (Chiaramonte et al. 1999a, 2001; Magalhaes et al. 2004; Alves Oliveira et al. 2006; Ta, 2008).”
BackgroundInfluentialFlamme, A. C. L., Patton, E. A., & Pearce, E. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.12.7445-7452.2001 · Cited by 31
“Although IL-13, which is a key profibrotic cytokine (7), is increased in anti-IFN- treated IL-4 / mice, it does not reach the levels found in WT mice (Fig.”
BackgroundLiu, T., Barrett, N. A., Kanaoka, Y., Buchheit, K. M., Laidlaw, T. M., Garofalo, D., Lai, J., Katz, H. R., Feng, C., & Boyce, J. A. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0134-8 · Cited by 32
IL-13 Induces YY1 through the AKT Pathway in Lung Fibroblasts
Guo, J., Yao, H., Lin, X., Xu, H., Dean, D. A., Zhu, Z., Liu, G., & Sime, P. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119039 · Cited by 31
“Among them, IL-13 is thought to be important cytokine in the pathogenesis of asthma, and more recently has been shown to play a pivotal role in a number of fibrotic diseases including hepatic and pulmonary fibrosis, and nodular sclerosing Hodgkin’s disease [6,7,8,9,10,11,12].”
Malahias, M., Birch, G. A., Zhong, H., Sideris, A., Valle, A. G. D., Sculco, P. K., & Kirksey, M. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.02.046 · Cited by 31
“Finally, when IL-13 was inhibited independently, it was identified as the dominant effector cytokine of fibrosis in several experimental models [14, 15].”
BackgroundInterference with immune function by HTLV-1
Goon, P. K. C., & Bangham, C. R. M. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02524.x · Cited by 32
Chizzolini, C. (1999) · Springer Seminars in Immunopathology · doi:10.1007/s002810000035 · Cited by 34
“In vivo - Anti-IL-4 treatment reduces fibrosis in TSK-2 mice [102] - IL-13 inhibitor blocks development of mouse hepatic fibrosis [23] in schistosomiasis - Irradiation-induced pulmonary fibrosis in rats correlates [ 19] with higher levels of IL-4 mRNA and protein tissue expression - Pulmonary expression of IL-13 in mi…”
BackgroundSevere Schistosomiasis in the Absence of Interleukin-4 (IL-4) Is IL-12 Independent
Patton, E. A., Brunet, L. R., Flamme, A. C. L., Pedras-Vasconcelos, J., Köpf, M., & Pearce, E. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.1.589-592.2001 · Cited by 29
“In the absence of IL-4, spleen cells from schistosome-infected mice produce lower levels of type 2 cytokines (IL-5, IL-10, and IL-13) and higher levels of inflammatory mediators, including gamma interferon (IFN-g), tumor necrosis factor alpha (TNFa), and nitric oxide (NO) (2, 5, 9, 15).”
BackgroundWong, S., Ting, Y., Yong, Y.-K., Tan, H.-Y., Barathan, M., Riazalhosseini, B., Bee, C. J., Tee, K. K., Larsson, M., Velu, V., et al. (2021) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2021.1876245 · Cited by 29
“IL13 has also been regarded as a key mediator for tissue fibrosis, particularly involving the liver [45,46] and lung [47–49].”
BackgroundBaraut, J., Farge, D., Jean‐Louis, F., Masse, I., Grigore, E. I., Arruda, L. C. M., Lamartine, J., Verrecchia, F., & Michel, L. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0708-0 · Cited by 31
“Inhibition of IL-4 and IL-13 in an independent way identified IL-13 as the dominant effector cytokine of fibrosis [31].”
BackgroundTH-1 and TH-2 Cytokines in Stable Chronic Alcoholics
González‐Reimers, E., Santolaria-Fernández, F., García, M., González-Pérez, J. M., de la Vega-Prieto, M. J., Medina-Vega, L., Martín-González, C., & Durán-Castellón, M. C. (2012) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags041 · Cited by 30
Cho, S., Roh, K., Park, J., Park, Y. S., Lee, M., Cho, S., Kil, E., Cho, M.-J., Oh, J. S., Byun, H.-S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00085-z · Cited by 28
Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis
Kumar, V., Kumar, V., Luo, J., & Mahato, R. I. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.08.022 · Cited by 30
Li, X., Shen, J., Zhong, Z., Wen, H., Luo, Q., & Wei, W. (2009) · Journal of Parasitology · doi:10.1645/ge-1994.1 · Cited by 27
Mutengo, M. M., Mduluza, T., Kelly, P. M., Mwansa, J. C. L., Kwenda, G., Musonda, P., & Chipeta, J. (2018) · Journal of Parasitology Research · doi:10.1155/2018/9754060 · Cited by 27
Figliuolo, V. R., Vanzan, D. F., & Pyrrho, A. D. S. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.11.011 · Cited by 28
Decoy Receptors in the Regulation of T Helper Cell Type 2 Responses
McKenzie, A. N. J., & Fallon, P. G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030096 · Cited by 28
“Similar findings using an IL-13 antagonist have also been reported (25).”
BackgroundResultOshima, Y., & Puri, R. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010159200 · Cited by 29
Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis
Hua-Huy, T., & Dinh‐Xuan, A. T. (2015) · Pathologie Biologie · doi:10.1016/j.patbio.2015.03.003 · Cited by 26
“Schistosoma mansoni showed a crucial role of IL-13 in hepatic fibrosis due to chronic bearing of parasites’ eggs [34].”
BackgroundRecombinant ST2 boosts hepatic Th2 response in vivo
Amatucci, A., Novobrantseva, T. I., Gilbride, K. J., Brickelmaier, M., Hochman, P. S., & Ibraghimov, A. R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006625 · Cited by 28
“IL-13 can induce tissue fibrosis via direct stimulation of collagen production by activated fibroblasts [ 35 , 36], as well as through activation of the major fibrogenic cytokine TGF- [38].”
Interleukin-13 is involved in the formation of liver fibrosis in Clonorchis sinensis-infected mice
Xu, Y., Liang, P., Bian, M., Chen, W., Wang, X., Lin, J., Shang, M., Qu, H., Wu, Z., Huang, Y., et al. (2016) · Parasitology Research · doi:10.1007/s00436-016-5012-7 · Cited by 27
Interleukin 13 and the evolution of asthma therapy.
Grünig, G., Corry, D. B., Reibman, J., & Wills-Karp, M. A. (2012) · Europe PMC (PubMed Central) · Cited by 25
Contribution of myeloid cell subsets to liver fibrosis in parasite infection
Beschin, A., BAETSELIER, P. D., & Ginderachter, J. A. V. (2012) · The Journal of Pathology · doi:10.1002/path.4112 · Cited by 28
Dunne, D. W., Vennervald, B. J., Booth, M., Joseph, S., Fitzsimmons, C. M., Cahen, P., STURROCK, R. F., Ouma, J. H., Mwatha, J. K., Kimani, G., et al. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.03.016 · Cited by 25
Nono, J. K., Ndlovu, H., Aziz, N. A., Mpotje, T., Hlaka, L., & Brombacher, F. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005861 · Cited by 27
Souza, A. L. S., Souza, P. R., Pereira, C. A. J., Fernandes, A., Guabiraba, R., Russo, R. C., Vieira, L. Q., Corrêa, A., Teixeira, M. M., & Negrão‐Corrêa, D. A. (2011) · Infection and Immunity · doi:10.1128/iai.00502-10 · Cited by 25
“mansoni-induced fibrosis is well established for mice (8, 9, 10, 17, 25, 31, 32), results which have been confirmed for humans (12, 14, 30).”
Rieder, F., Bettenworth, D., Imai, J., & Inagaki, Y. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000445135 · Cited by 27
ILC2s in infectious diseases and organ-specific fibrosis
Kindermann, M., Knipfer, L., Atreya, I., & Wirtz, S. J. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0677-x · Cited by 27
“mansoni-infected or egg-treated mice [82, 83].”
Izuhara, K., Umeshita-Suyama, R., Akaiwa, M., Shirakawa, T., Deichmann, K. A., Arima, K., Hamasaki, N., & Hopkin, J. M. (2001) · Springer eBooks · doi:10.1007/978-94-015-9702-9_10 · Cited by 24
Chemokine responses in schistosomal antigen‐elicited granuloma formation*
Chiu, B., & Chensue, S. W. (2002) · Parasite Immunology · doi:10.1046/j.1365-3024.2002.00466.x · Cited by 26
SUGAWARA, Y., AZUMA, N., ONODERA, S., TSUNOKA, Y., & Morimoto, M. (2010) · Journal of Veterinary Medical Science · doi:10.1292/jvms.10-0269 · Cited by 23
“Since Th2 cytokines and AAMacs have been associated with fibrotic tissue remodeling [4, 24], it is suggested that local tissue repair was inhibited or delayed due to Th2 cytokine insufficiency in the aged mice.”
BackgroundAttenuation of Dupuytren’s fibrosis via targeting of the STAT1 modulated IL-13Rα1 response
Akbar, M., Melchor, E. G., Chilaka, S., Little, K. J., Sood, S., Reilly, J. H., Liew, F. Y., McInnes, I. B., & Millar, N. L. (2020) · Science Advances · doi:10.1126/sciadv.aaz8272 · Cited by 24
“IL-13 is synonymous with fibrotic disorders (19, 36, 37), and we established the increased presence of mast cell–derived IL-13 in Dupuytren’s tissue.”
BackgroundFarhadihosseinabadi, B., Salimi, M., Kazemi, B., Samadikuchaksaraei, A., Ghanbarian, H., Mozafari, M., & Niknejad, H. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109389 · Cited by 23
Vale, N., Gouveia, M. J., & Gärtner, F. (2020) · Biomolecules · doi:10.3390/biom10030350 · Cited by 22
“It is possible to conduct several types of studies using these models, for example, for novel therapies including novel drugs or combination of novel compounds, vaccines or immunotherapy, characterization of infection and ultimately cancer associated to infection [26,85,86].”
BackgroundMicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7
Luo, X., Zhang, D., Xie, J., Su, Q., He, X., Bai, R., Gao, G., & Pan, W. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.10.002 · Cited by 22
Immune mechanisms in fibrotic pulmonary sarcoidosis
Weeratunga, P. N., Möller, D. R., & Ho, L. (2022) · European Respiratory Review · doi:10.1183/16000617.0178-2022 · Cited by 24
Zhang, L., Mi, J., Yu, Y., Yao, H., Chen, H., Li, M., & Cao, X. (2001) · Parasite Immunology · doi:10.1046/j.1365-3024.2001.00349.x · Cited by 22
“…®brosis are not fully understood, increasing evidence suggest that both the granulomas and hepatic ®brosis in mice are immunologically mediated lesions which are associated with upregulation of Th2 cytokine response and downregulation of Th1 response (Chiaramonte et al. 1999, Fallon et al. 2000).”
BackgroundJakubzick, C., Kunkel, S. L., Joshi, B. H., Puri, R. K., & Hogaboam, C. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64405-7 · Cited by 26
“Previous studies have shown that IL-13 is a major mediator of fibroblast activation and tissue fibrosis.(17,44,45) In the present study, the peribronchial distribution of extracellular matrix and fibroblasts, revealed by the Masson trichrome stain, was pronounced in the granulomas of the control groups at days 8 and 1…”
BackgroundImmunological Orchestration of Liver Fibrosis
Tanaka, H., Leung, P. S. C., Kenny, T. P., Gershwin, M. E., & Bowlus, C. L. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8323-1 · Cited by 22
“Th2 cells coordinate the immune responses activating macrophages and inducing collagen production by HSCs with IL-4 and IL-12 [11–13] (Fig.”
BackgroundOloris, S. C. S., Mesnil, M., Reis, V. N. D. S., Sakai, M., Matsuzaki, P., Fonseca, E. D. S. M., da Silva, T. C., Avanzo, J. L., Sinhorini, I. L., Guerra, J. L., et al. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.12.030 · Cited by 21
Allam, G. A., Abuelsaad, A. S. A., Alblihed, M. A., & Alsulaimani, A. A. (2016) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2016.1189561 · Cited by 21
Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis
An, S. Y., Petrescu, A. D., & DeMorrow, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.645703 · Cited by 23
“Also, they show that blockade of IL-13 prevented liver fibrogenesis (Chiaramonte et al., 1999; Fallon et al., 2000; Chiaramonte et al., 2001).”
BackgroundCytokine profile associated with human chronic schistosomiasis mansoni
Magalhães, A. S., Miranda, D. G., Miranda, R. G., Araújo, M. I., de Jesus, A. A., Silva, Â., Santana, L. B., Pearce, E. J., Carvalho, E. M., & de Jesus, A. R. (2004) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762004000900004 · Cited by 21
“In mice, IL-4 and IL-13 play a major role in egg granuloma formation, and IL-13 was shown to play a significant role in the development of hepatic fibrosis ( Chiaramonte et al. 1999, 2001, Monica et al. 2003).”
Gender-Related Cytokine Patterns in Sera of Schistosomiasis Patients with Symmers' Fibrosis
Silva-Teixeira, D. N., Contigli, C., Lambertucci, J. R., Serufo, J. C., & Rodrigues, V. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.3.627-630.2004 · Cited by 21
Role of the Transcriptional Repressor BCL6 in Allergic Response and Inflammation
Arima, M., Fukuda, T., & Tokuhisa, T. (2008) · World Allergy Organization Journal · doi:10.1097/wox.0b013e31817dc522 · Cited by 22
Evaluation of peri-implant mucosa: Clinical, histopathological and immunological aspects
de Araújo, M. F., Filho, A. F. L., da Silva, G. P., de Melo, M. L. R., Napimoga, M. H., Rodrigues, D. B. R., Alves, P. M., & Pereira, S. A. D. L. (2014) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.01.011 · Cited by 25
Reißing, J., Berres, M., Strnad, P., Wree, A., Inzaugarat, M. E., Trautwein, C., Bruns, T., & Zimmermann, H. W. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.011 · Cited by 21
“28,41,42 In noninfectious diseases, such as systemic sclerosis and rheumatoid arthritis, 43 – 46 IL13 is involved in extrahepatic fi brogenesis and increased IL13 levels have been reported in human liver steatosis.”
BackgroundLow Serum Interleukin-13 Levels Correlate with Poorer Prognoses for Colorectal Cancer Patients
Saigusa, S., Tanaka, K., Inoue, Y., Toiyama, Y., Okugawa, Y., Iwata, T., Mohri, Y., & Kusunoki, M. (2014) · International Surgery · doi:10.9738/intsurg-d-13-00259.1 · Cited by 20
Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
Chen, I., Liu, Y., Wu, Y.-H., Lo, S., Dai, Z., Hsu, J., & Tseng, Y. (2022) · Cells · doi:10.3390/cells11091543 · Cited by 22
“TH-1 effector T cells are thought to induce anti-fibrotic activities through the production of interferon-γ [83], and TH-2 effector T cells are thought to promote fibrosis through the production of some cytokines, such as IL-4, IL-5, and IL-13 [84,85].”
BackgroundZhang, L., Pan, J., Yao, H., Wj, S., Xia, D. J., Wang, Q., He, L., Wang, J., & Cao, X. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301524 · Cited by 19
The IL-4/IL-13 signaling axis promotes prostatic fibrosis
D’Arcy, Q., Gharaee‐Kermani, M., Zhilin-Roth, A., & Macoska, J. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275064 · Cited by 21
“Several studies have shown that IL-4 and IL-13, which share a common JAK/STAT6 signaling axis, promote fibrillar collagen secretion in multiple organ systems (reviewed in [16], most notably in the lung [17, 18], the kidney [19, 20], and the liver [17, 21].”
BackgroundFrom pathogenesis to therapy – Perspective on treatment strategies in fibrotic diseases
Ramming, A., Dees, C., & Distler, J. H. W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.06.012 · Cited by 19
Metwali, A., Blum, A. M., Elliott, D. E., & Weinstock, J. V. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5651-5658.2002 · Cited by 19
“IL-4 and IL-13, which signal via the Stat6 pathway, are important for phenotypic expression of the Th2 response in schistosomiasis (6, 11, 28).”
Background
Metadata
- Authors
- Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 777-785
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408441
- OpenAlex
- W1975021657
- Cited by
- 603
- References
- 47
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 7 · 2023: 8 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 13 · 2018: 34 · 2017: 18 · 2016: 30 · 2015: 28 · 2014: 35 · 2013: 23 · 2012: 30
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-13, liver fibrosis, schistosomiasis, Schistosoma mansoni, Th2 cytokines, IL-4, granuloma formation, collagen synthesis, fibroblasts, procollagen mRNA, antifibrotic therapy
- MeSH terms
- Animals, Female, Liver, Liver Cirrhosis, Experimental, Mice, Inbred C57BL, Procollagen, RNA, Messenger, Schistosomiasis mansoni, Interleukin-4, Cytokines, 3T3 Cells, Mice, Knockout, Th1 Cells, Th2 Cells, Interleukin-13, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.